These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 10468662)

  • 1. Effects of recombinant erythropoietin (r-HuEPO) on plasma glucose concentration in endurance-trained rats.
    Cayla J; Lavoie C; Gareau R; Duvallet A
    Acta Physiol Scand; 1999 Jul; 166(3):247-9. PubMed ID: 10468662
    [No Abstract]   [Full Text] [Related]  

  • 2. Human recombinant erythropoietin alters the flow-dependent vasodilatation of in vitro perfused rat mesenteric arteries with unbalanced endothelial endothelin-1 / nitric oxide ratio.
    Barhoumi T; Jallat I; Berthelot A; Laurant P
    Can J Physiol Pharmacol; 2011 Jun; 89(6):435-43. PubMed ID: 21777087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of caffeine on glycogenolysis during exercise in endurance trained rats.
    Arogyasami J; Yang HT; Winder WW
    Med Sci Sports Exerc; 1989 Apr; 21(2):173-7. PubMed ID: 2709979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of recombinant human erythropoietin treatment on the endurance performance of Sprague-Dawley rats.
    Verbrugge DJ; Goodnough LT
    Scand J Clin Lab Invest; 1994 Feb; 54(1):55-9. PubMed ID: 8171272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct evidence for erythropoietin-induced release of endothelin from peripheral vascular tissue.
    Katoh K; Mizuno K; Hashimoto S; Okazaki K; Asahi K; Kuriki M; Yamada D; Fukuchi S
    Life Sci; 1994; 54(16):PL253-9. PubMed ID: 8152333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin and autologous blood donation.
    Levine EA; Rosen AL; Gould SA; Sehgal LR; Egrie JC; Browne JK; Sehgal HL; Moss GS
    Surgery; 1988 Aug; 104(2):365-9. PubMed ID: 3400066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin induces a shift of muscle phenotype from fast glycolytic to slow oxidative.
    Cayla JL; Maire P; Duvallet A; Wahrmann JP
    Int J Sports Med; 2008 Jun; 29(6):460-5. PubMed ID: 18080952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Numerical and functional alterations in T and B lymphocyte subpopulations in CAPD patients treated with recombinant human erythropoietin].
    Tanabe R
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1159-68. PubMed ID: 7815748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of recombinant human erythropoietin (r-HuEPO) on left ventricular mass and left ventricular hemodynamics in hemodialysis patients.
    Minagawa T; Hirano T; Takada N; Ishiguro M; Ohtsuka H
    Nihon Jinzo Gakkai Shi; 1994 Aug; 36(8):934-41. PubMed ID: 7933670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related differences in erythropoietic response to recombinant human erythropoietin: comparison in adult and infant rhesus monkeys.
    George JW; Bracco CA; Shannon KM; Davis GJ; Smith IL; Phibbs RH; Hendrickx AG
    Pediatr Res; 1990 Dec; 28(6):567-71. PubMed ID: 2284151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogenolytic effect of adrenaline in skeletal muscle of rats adapted to endurance exercise.
    Górski J
    Acta Physiol Pol; 1978; 29(5):437-41. PubMed ID: 747105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin.
    Romijn JA
    N Engl J Med; 1991 Oct; 325(16):1176-7. PubMed ID: 1891030
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in rats.
    Kato M; Okano K; Sakamoto Y; Miura K; Uchimura T; Saito K
    Arzneimittelforschung; 2001 Jan; 51(1):91-5. PubMed ID: 11215332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin (rHuEPO) doping: effects of exercise on anaerobic metabolism in rats.
    Lavoie C; Diguet A; Milot M; Gareau R
    Int J Sports Med; 1998 May; 19(4):281-6. PubMed ID: 9657370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between muscle glycogen and blood glucose during exercise.
    Hargreaves M
    Exerc Sport Sci Rev; 1997; 25():21-39. PubMed ID: 9213087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Squadrito G; Campo GM; Arlotta M; Quartarone C; Saitta A; Caputi AP
    Br J Pharmacol; 1999 May; 127(2):482-8. PubMed ID: 10385249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of hydrocortisone on physical endurance and various biochemical indicators in rats].
    Marev R; Lambev Ts
    Eksp Med Morfol; 1988; 27(3):31-4. PubMed ID: 3220043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.